Baseline population demographic characteristics and risk prevalence
| Author(s) | Publish (year) | Trial (study name) | Total (n) | Follow-up (year) | Incident HF (n) | Cumu incidence (%) | Age (years) | Male (%) | Risk ratio | Stats model used | Smoke (%) | BMI | DM (%) | CAD (%) | LVH (%) | HTN (%) | VHD (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ho et al23 | 1993 | Framingham and offspring (USA) | 9405* | 40* | 652* | RR | CPH | ||||||||||
| Kannel et al24 | 1999 | 15 267 pe* | 38* | 486* | OR | PLR | ||||||||||||
| Ho et al25 | 2013 | 6340 | 8 | 512 | 8.1 | 60±12 | 46 | HR | CPH | 22 | 27±4 | 7 | 8 | 8 | 46 | 1 | ||
| 2 | Butler et al26 Kalogeropoulos et al17 | 2008 2009 | Health ABC study (USA) | 2934 | 7 | 258 | 8.8 | 74±2.9 | 48 | HR RR | CPH MH | 56 | 27.3±4.8 | 15 | 17 | 12 | 43 | |
| 3 | He et al15 | 2001 | NHANES (USA) | 13 643 | 19 | 1382 | 10.1 | 50±15 | 41 | Risk ratio | CPH | 35 | 25.6±5 | 4 | 5 | 28 | 5 | |
| 4 | Agarwal et al27 | 2012 | ARIC (USA) | 13 555 | 16 | 1487 | 11.0 | 54±5.8 | 45 | HR | CPH | 25 | 27.6±5.2 | 10 | 4 | 2 | 1 | |
| 5 | Goyal et al28 | 2010 | Million P-Yr (USA) | 359 947 | 5 | 4001 | 1.1 | 38±14 | 47 | HR | CPH | 3 | 1 | 12 | 1 | |||
| 6 | Bahrami et al29 Bahrami et al30 | 2008 2008 | MESA (USA) | 6814 | 4 | 79 | 1.2 | 65±0.7 | 47 | HR | CPH | 49 | 28.4±0.1 | 14 | 10 | 48 | ||
| 7 | Gottdiener et al16 Mujib et al21 | 2000 2010 | Cardio Vascular Health (USA) | 5625 | 12 | 597 | 10.6 | 73±4.5 | 42 | RR HR | CPH CPH | 54 | 17 | 58 | ||||
| 8 | Chen et al31 | 1999 | EPESE (USA) | 1749 | 8 | 173 | 9.9 | 74±6.8 | 41 | HR | CPH | 78 | 11 | 54 | ||||
| 9 | Bibbins-Domingo et al32 | 2009 | CARDIA (USA) | 5115 | 20 | 27 | 0.5 | 24±3.5 | 45 | HR | CPH | 31 | 24.5±4.8 | 2 | 6 | 3 | ||
| 10 | Ingelsson et al33 | 2005 | ULSAM (Sweden) | 2321 | 29 | 259 | 11.2 | 50±0.0 | 100 | HR | CPH | 51 | 25±3.2 | 6 | 0 | 2 | 43 | |
| 11 | Wang et al34 | 2010 | Kuopio (Finland) | 1032 | 21 | 303 | 29.4 | 69±2.8 | 38 | HR | CPH | 29 | 27.2±4.0 | 17 | 7 | 31 | 26 | |
| 12 | Aronow et al35 | 1999 | Mt Sinai (USA) | 2902 | 4 | 794 | 27.4 | 81±8.0 | 32 | HR | CPH | 25 | 44 | 46 | ||||
| 13 | Smith et al36 | 2010 | MDCS (Sweden) | 5187 | 14 | 112 | 2.2 | 58±5.9 | 41 | HR | CPH | 27 | 25.7±3.9 | 8 | 2 | 17 | ||
| 14 | Kenchaiah et al37 | 2009 | Physician's heart (USA) | 21 094 | 21 | 1109 | 5.3 | 53±9.4 | 100 | HR | CPH | 48 | 24.8±1.4 | 3 | 9 | 24 | ||
| 15 | Brouwers et al38 | 2013 | Prevend (the Netherlands) | 8592 | 12 | 374 | 4.4 | 49±12 | 50 | HR | CPH | 38 | 26±4.0 | 4 | 6 | 32 | ||
| Sum | 1993–2013 | 15 studies | 456 850 | 198 | 11 467 | |||||||||||||
| Mean (weighted) | 30 457 | 7 | 3323 | 0.97 | 42 | 49 | 39 | 26 | 4 | 2.23 | 6 | 16 | 1 | |||||
| SD (weighted) | 1.0 | 811 | 0.11 | 12.6 | 9 | 2.70 | 3 | 1 | 0.23 | 1 | 3 | 0.2 | ||||||
| Maximum | 359 947 | 29 | 4001 | 29.36 | 81 | 100 | 78 | 28 | 25 | 44 | 31 | 58 | 5 | |||||
| Minimum | 1032 | 4 | 27 | 0.53 | 24 | 32 | 22 | 25 | 2 | 0.3 | 1.5 | 3.0 | 0.5 |
*Duplicated counts from a single study, not included in total and cumulated incidence.
ARIC, the Atherosclerosis Risk in Communities; BMI, body mass index; CAD, coronary artery disease; CARDIA, Coronary Artery Risk Development in Young Adults; CPH, Cox proportional hazard; Cumu incidence, cumulative incident rate; CVH, Cardio Vascular Health study; DM, diabetes mellitus; EPESE, Established Population for Epidemiologic Studies of the Elderly programme; FHS, Framingham Heart Study; HABC, Health Aging and Body Composite Study; HF, heart failure; HTN, hypertension; Kuopio, Kuopio Finland study; LVH, left ventricular hypertrophy; MDCS, the Malmo Diet and Cancer Study in Swedish people; MESA, Multi-Ethnic Study of Atherosclerosis; MH, Mantel-Haenszel; Million P-Yr, One Million Person-Year study; Mt Sinai, Study at Mt Sinai; NHANES, National Health Nutrition Examination Survey; pe, person examination; Physician Heart, the Physician heart study; PLR, pooled logistic regression; Prevend, Prevention of Renal and Vascular End-stage Disease; P-Yr, person year; RR, relative risk; ULSAM, Uppsala Longitudinal Study of Adult men; VHD, valvular heart disease.